130 related articles for article (PubMed ID: 25670811)
1. Association between ultrasonography screening and mortality in patients with hepatocellular carcinoma: a nationwide cohort study.
Wu CY; Hsu YC; Ho HJ; Chen YJ; Lee TY; Lin JT
Gut; 2016 Apr; 65(4):693-701. PubMed ID: 25670811
[TBL] [Abstract][Full Text] [Related]
2. Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high risk group in Taiwan.
Chen TH; Chen CJ; Yen MF; Lu SN; Sun CA; Huang GT; Yang PM; Lee HS; Duffy SW
Int J Cancer; 2002 Mar; 98(2):257-61. PubMed ID: 11857416
[TBL] [Abstract][Full Text] [Related]
3. Improved Survival in Patients with Viral Hepatitis-Induced Hepatocellular Carcinoma Undergoing Recommended Abdominal Ultrasound Surveillance in Ontario: A Population-Based Retrospective Cohort Study.
Thein HH; Campitelli MA; Yeung LT; Zaheen A; Yoshida EM; Earle CC
PLoS One; 2015; 10(9):e0138907. PubMed ID: 26398404
[TBL] [Abstract][Full Text] [Related]
4. Community-based screening for hepatocellular carcinoma in elderly residents in a hepatitis B- and C-endemic area.
Huang YC; Huang CF; Chang KC; Hung SF; Wang JH; Hung CH; Chen CH; Tseng PL; Kee KM; Yen YH; Tsai PS; Tsai CC; Lu SN
J Gastroenterol Hepatol; 2011 Jan; 26(1):129-34. PubMed ID: 21175806
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of abdominal ultrasonography mass screening for hepatocellular carcinoma in Taiwan.
Yeh YP; Hu TH; Cho PY; Chen HH; Yen AM; Chen SL; Chiu SY; Fann JC; Su WW; Fang YJ; Chen ST; San HC; Chen HP; Liao CS;
Hepatology; 2014 May; 59(5):1840-9. PubMed ID: 24002724
[TBL] [Abstract][Full Text] [Related]
6. Opposite association between diabetes, dyslipidemia, and hepatocellular carcinoma mortality in the middle-aged and elderly.
Chiang CH; Lee LT; Hung SH; Lin WY; Hung HF; Yang WS; Sung PK; Huang KC
Hepatology; 2014 Jun; 59(6):2207-15. PubMed ID: 24425422
[TBL] [Abstract][Full Text] [Related]
7. Optimal treatment increased survival of hepatocellular carcinoma patients detected with community-based screening.
Tseng PL; Wang JH; Tung HD; Hung CH; Kee KM; Chen CH; Chang KC; Lee CM; Changchien CS; Chen PF; Tsai LS; Lu SN
J Gastroenterol Hepatol; 2010 Aug; 25(8):1426-34. PubMed ID: 20659234
[TBL] [Abstract][Full Text] [Related]
8. Association of nucleos(t)ide analogue therapy with reduced risk of hepatocellular carcinoma in patients with chronic hepatitis B: a nationwide cohort study.
Wu CY; Lin JT; Ho HJ; Su CW; Lee TY; Wang SY; Wu C; Wu JC
Gastroenterology; 2014 Jul; 147(1):143-151.e5. PubMed ID: 24704525
[TBL] [Abstract][Full Text] [Related]
9. [Association between ultrasound screening frequency and mortality in patients with hepatocellular carcinoma].
Song JJ; Lu WY; Zhao ZW; Fan XX; Tu JF; Ji JS
Zhonghua Yi Xue Za Zhi; 2016 Dec; 96(45):3652-3655. PubMed ID: 27978901
[No Abstract] [Full Text] [Related]
10. Optimal Intervals of Ultrasonography Screening for Early Diagnosis of Hepatocellular Carcinoma in Taiwan.
Kuo SC; Lin CN; Lin YJ; Chen WY; Hwang JS; Wang JD
JAMA Netw Open; 2021 Jun; 4(6):e2114680. PubMed ID: 34165580
[TBL] [Abstract][Full Text] [Related]
11. Screening for hepatocellular carcinoma among veterans with hepatitis C on disease stage, treatment received, and survival.
Leykum LK; El-Serag HB; Cornell J; Papadopoulos KP
Clin Gastroenterol Hepatol; 2007 Apr; 5(4):508-12. PubMed ID: 17382601
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of AFP and ultrasound tests on hepatocellular carcinoma mortality in HCV-infected patients in the USA.
El-Serag HB; Kramer JR; Chen GJ; Duan Z; Richardson PA; Davila JA
Gut; 2011 Jul; 60(7):992-7. PubMed ID: 21257990
[TBL] [Abstract][Full Text] [Related]
13. Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience.
Yuen MF; Cheng CC; Lauder IJ; Lam SK; Ooi CG; Lai CL
Hepatology; 2000 Feb; 31(2):330-5. PubMed ID: 10655254
[TBL] [Abstract][Full Text] [Related]
14. Nucleos(t)ide analogues associated with a reduced risk of hepatocellular carcinoma in hepatitis B patients: a population-based cohort study.
Wang JP; Kao FY; Wu CY; Hung YP; Chao Y; Chou YJ; Li CP
Cancer; 2015 May; 121(9):1446-55. PubMed ID: 25537961
[TBL] [Abstract][Full Text] [Related]
15. Randomized controlled trial of screening for hepatocellular carcinoma.
Zhang BH; Yang BH; Tang ZY
J Cancer Res Clin Oncol; 2004 Jul; 130(7):417-22. PubMed ID: 15042359
[TBL] [Abstract][Full Text] [Related]
16. Does screening or surveillance for primary hepatocellular carcinoma with ultrasonography improve the prognosis of patients?
Yu EW; Chie WC; Chen TH
Cancer J; 2004; 10(5):317-25. PubMed ID: 15530261
[TBL] [Abstract][Full Text] [Related]
17. Risk for hepatocellular carcinoma in patients with alcoholic cirrhosis: a Danish nationwide cohort study.
Jepsen P; Ott P; Andersen PK; Sørensen HT; Vilstrup H
Ann Intern Med; 2012 Jun; 156(12):841-7, W295. PubMed ID: 22711076
[TBL] [Abstract][Full Text] [Related]
18. Postoperative peg-interferon plus ribavirin is associated with reduced recurrence of hepatitis C virus-related hepatocellular carcinoma.
Hsu YC; Ho HJ; Wu MS; Lin JT; Wu CY
Hepatology; 2013 Jul; 58(1):150-7. PubMed ID: 23389758
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and cost of a hepatocellular carcinoma screening program at an Australian teaching hospital.
Qian MY; Yuwei J R; Angus P; Schelleman T; Johnson L; Gow P
J Gastroenterol Hepatol; 2010 May; 25(5):951-6. PubMed ID: 20546449
[TBL] [Abstract][Full Text] [Related]
20. Association between nucleos(t)ide analog and tumor recurrence in hepatitis B virus-related hepatocellular carcinoma after radiofrequency ablation.
Lee TY; Lin JT; Zeng YS; Chen YJ; Wu MS; Wu CY
Hepatology; 2016 May; 63(5):1517-27. PubMed ID: 26426978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
